T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy

Kidney Int. 2008 Apr;73(7):826-34. doi: 10.1038/sj.ki.5002793. Epub 2008 Jan 16.

Abstract

T-type calcium channel blockers have been previously shown to protect glomeruli from hypertension by regulating renal arteriolar tone. To examine whether blockade of these channels has a role in protection against tubulointerstitial damage, we used a stereo-selective T-type calcium channel blocker R(-)-efonidipine and studied its effect on the progression of this type of renal injury in spontaneously hypertensive rats that had undergone subtotal nephrectomy. Treatment with racemic efonidipine for 7 weeks significantly reduced systolic blood pressure and proteinuria. The R(-)-enantiomer, however, had no effect on blood pressure but significantly reduced proteinuria compared to vehicle-treated rats. Both agents blunted the increase in tubulointerstitial fibrosis, renal expression of alpha-smooth muscle actin and vimentin along with transforming growth factor-beta (TGF-beta)-induced renal Rho-kinase activity seen in the control group. Subtotal nephrectomy enhanced renal T-type calcium channel alpha1G subunit expression mimicked in angiotensin II-stimulated mesangial cells or TGF-beta-stimulated proximal tubular cells. Our study shows that T-type calcium channel blockade has renal protective actions that depend not only on hemodynamic effects but also pertain to Rho-kinase activity, tubulointerstitial fibrosis, and epithelial-mesenchymal transitions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Channel Blockers / therapeutic use*
  • Calcium Channels, T-Type / drug effects*
  • Chronic Disease
  • Dihydropyridines / therapeutic use*
  • Hypertension / complications
  • Hypertension / drug therapy
  • Kidney Diseases / etiology
  • Kidney Diseases / prevention & control*
  • Male
  • Nephrectomy / methods
  • Nitrophenols / therapeutic use*
  • Organophosphorus Compounds / therapeutic use
  • Rats
  • Rats, Inbred SHR

Substances

  • Calcium Channel Blockers
  • Calcium Channels, T-Type
  • Dihydropyridines
  • Nitrophenols
  • Organophosphorus Compounds
  • efonidipine